Award type :
Product Development Award
Product Development Award
Product type :
Vaccines
Vaccines
Award year :
2021
2021
Project start date :
09 / 27 / 2021
09 / 27 / 2021
Project end date :
09 / 26 / 2022
09 / 26 / 2022
Project duration (months) :
12
12
Development stage :
Phase 1
Phase 1
Target disease :
COVID-19
COVID-19
Region served :
Low- and Middle-Income Countries
Low- and Middle-Income Countries
Recipient organization / Country of funding recipient organization :
Abion / Republic of Korea
Abion / Republic of Korea
Collaborator(s) / Country :
Raphas / Republic of Korea
Raphas / Republic of Korea
Funding amount(KRW) :
500,000,000
500,000,000
Abion is collaborating with Raphas to develop a DNA vaccine for COVID-19 using a microarray patch combined with a portable electroporation device (eMAP) and powered by an integrated battery. This unique combination of various technologies of DNA vaccine, microarray patch and electroporation could lead to significant advancement in delivery methods for DNA vaccines. If validated, the platform technology has the potential to enable the rapid production of DNA vaccines for future COVID-19 variants and other diseases.